(Q36277918)

13 August 2017

1 reference

title

Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain (English)

1 reference

13 August 2017

0 references

Daniel P Wermeling

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

25

1 reference

13 August 2017

issue

8

1 reference

13 August 2017

page(s)

1084-1094

1 reference

A new Conus peptide ligand for mammalian presynaptic Ca2+ channels

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Antagonists of neuronal calcium channels: structure, function, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Drugs from the seas - current status and microbiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Three-Dimensional Structure in Solution of the Calcium Channel Blocker .omega.-Conotoxin MVIIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

A consensus structure for omega-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: comparison of MVIIA, SVIB and SNX-202

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Binding of chimeric analogs of omega-conotoxin MVIIA and MVIIC to the N- and P/Q-type calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Cardiovascular and autonomic effects of omega-conotoxins MVIIA and CVID in conscious rabbits and isolated tissue assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Rank-order inhibition by omega-conotoxins in human and animal autonomic nerve preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

A hypothesis on the physiological basis for causalgia and related pains

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Role of calcium channels in the spinal transmission of nociceptive information from the mesentery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Differential effects of intrathecally administered N- and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

Ziconotide for the treatment of severe spasticity after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.8.1084

10.1592/PHCO.2005.25.8.1084

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference